Researchers at the University of Virginia School of Medicine say this finding could open the door to better ways to manage high blood pressure and other vascular diseases.

People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

Findings seen for individuals undergoing revascularization after non-ST-segment elevation myocardial infarction ...

kidney problems and more. The goal of the BPROAD study was to determine whether an intensive systolic blood pressure ...

Following propensity score standardised mortality ratio weighting adjustment for 98 covariates, hazard ratios and rate ...

Real-world data on GLP-1R agonists’ safety in heart failure and CKD patients was investigated using the TriNetX Research ...

Left untreated, it increases risk of stroke, heart failure, myocardial infarction, chronic kidney disease and dementia.

Patients with congestive heart failure post-myocardial infarction plus hypertension with impaired renal function should be treated with caution. There are no well controlled studies of eplerenone ...

The best diabetes medication if you have kidney disease can vary by the severity of your kidney damage. You may need to use one that does not require dose adjustment based on your kidney function.

Mohammad Ali Sheffeh, MD, from the Mayo Clinic in Rochester, Minnesota, and colleagues examined the efficacy of GLP-1 RA or SGLT-2i initiation for reducing mortality or cardiovascular events among ...

A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog medication, during heart surgeries involving bypass did not significantly reduce the ...

For ventricular tachycardia after myocardial infarction, outcomes are better with upfront catheter ablation than drug therapy ...